BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 8220128)

  • 21. The potential effect of short-course high-dose steroid on the maturation and apoptosis of leukemic cells in a child with acute megakaryoblastic leukemia.
    Hiçsönmez G; Cetin M; Okur H; Erdemli E; Gürgey A
    Leuk Lymphoma; 2003 Jun; 44(6):1037-42. PubMed ID: 12854906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia: in vitro drug sensitivity and outcome.
    Savaşan S; Buck S; Raimondi SC; Becton DL; Weinstein H; Chang M; Ravindranath Y
    Leuk Lymphoma; 2006 Oct; 47(10):2076-83. PubMed ID: 17071479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic impact of specific molecular profiles in pediatric acute megakaryoblastic leukemia in non-Down syndrome.
    Hara Y; Shiba N; Ohki K; Tabuchi K; Yamato G; Park MJ; Tomizawa D; Kinoshita A; Shimada A; Arakawa H; Saito AM; Kiyokawa N; Tawa A; Horibe K; Taga T; Adachi S; Taki T; Hayashi Y
    Genes Chromosomes Cancer; 2017 May; 56(5):394-404. PubMed ID: 28063190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
    Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
    Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.
    Ariffin H; Garcia JC; Daud SS; Ibrahim K; Aizah N; Ong GB; Chong LA; Mohamad Z
    Pediatr Blood Cancer; 2009 Jul; 53(1):108-11. PubMed ID: 19260099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Childhood acute megakaryoblastic leukemia with internalization of hemic cells.
    Shimizu H; Ui T; Sasaki K; Kawai S; Kaneko Y; Fujimoto T
    Am J Pediatr Hematol Oncol; 1990; 12(4):477-9. PubMed ID: 2285130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pan myeloid antigen-negative pediatric acute megakaryoblastic leukemia.
    Cetin N; Lorsbach RB
    Pediatr Blood Cancer; 2014 Nov; 61(11):2089-91. PubMed ID: 24962432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ultrastructural and ultracytochemical differences between megakaryoblastic leukemia in children and adults. Analysis of 49 patients.
    Eguchi M; Ozawa T; Sakakibara H; Sugita K; Iwama Y; Furukawa T
    Cancer; 1992 Jul; 70(2):451-8. PubMed ID: 1319816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The t(1;22) (p13;q13) is nonrandom and restricted to infants with acute megakaryoblastic leukemia: a Pediatric Oncology Group Study.
    Carroll A; Civin C; Schneider N; Dahl G; Pappo A; Bowman P; Emami A; Gross S; Alvarado C; Phillips C
    Blood; 1991 Aug; 78(3):748-52. PubMed ID: 1859887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
    Inaba H; Zhou Y; Abla O; Adachi S; Auvrignon A; Beverloo HB; de Bont E; Chang TT; Creutzig U; Dworzak M; Elitzur S; Fynn A; Forestier E; Hasle H; Liang DC; Lee V; Locatelli F; Masetti R; De Moerloose B; Reinhardt D; Rodriguez L; Van Roy N; Shen S; Taga T; Tomizawa D; Yeoh AE; Zimmermann M; Raimondi SC
    Blood; 2015 Sep; 126(13):1575-84. PubMed ID: 26215111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
    Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
    Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
    Kudo K; Kojima S; Tabuchi K; Yabe H; Tawa A; Imaizumi M; Hanada R; Hamamoto K; Kobayashi R; Morimoto A; Nakayama H; Tsuchida M; Horibe K; Kigasawa H; Tsukimoto I;
    J Clin Oncol; 2007 Dec; 25(34):5442-7. PubMed ID: 18048827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute megakaryoblastic leukemia with increased hematogones in children.
    Anton-Harisi M; Douna V; Baka M; Servitzoglou M; Kosmidis HV; Georgouli H; Anastasiou T
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e337-40. PubMed ID: 22983420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of MDR-1/P-glycoprotein in childhood acute megakaryoblastic leukemia cells.
    Ota S; Sato T; Kakuda H; Hirano K; Okimoto Y; Mori T; Nakazawa S; Kojima S; Matsuyama T; Tsuruo T
    Leuk Lymphoma; 1995 Nov; 19(5-6):431-6. PubMed ID: 8590843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunophenotype of Down syndrome acute myeloid leukemia and transient myeloproliferative disease differs significantly from other diseases with morphologically identical or similar blasts.
    Langebrake C; Creutzig U; Reinhardt D
    Klin Padiatr; 2005; 217(3):126-34. PubMed ID: 15858703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute megakaryoblastic leukemia associated with trisomy 21 demonstrates a distinct immunophenotype.
    Wang L; Peters JM; Fuda F; Li L; Karandikar NJ; Koduru P; Wang HY; Chen W
    Cytometry B Clin Cytom; 2015; 88(4):244-52. PubMed ID: 25361478
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review of the cytogenetic changes in acute megakaryoblastic leukemia: one disease or several?
    Lu G; Altman AJ; Benn PA
    Cancer Genet Cytogenet; 1993 Jun; 67(2):81-9. PubMed ID: 8330276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down syndrome, drug metabolism and chromosome 21.
    Taub JW; Ge Y
    Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
    Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.